BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21819617)

  • 1. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
    Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
    BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
    Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
    Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
    J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma.
    Takanami I; Takeuchi K; Naruke M
    Oncol Rep; 2000; 7(5):1065-7. PubMed ID: 10948339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
    Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
    J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
    Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
    J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
    Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
    Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
    Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
    Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
    Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
    Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
    Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
    World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of granulocyte colony stimulating factor in patients with non-small cell lung cancer and its clinicopathological significance].
    Wei LX; Chang WL; Guo AT; Tai YH; Sun L; Shi HY
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):721-5. PubMed ID: 22336152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
    Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
    Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.